Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 1
1967 2
1968 1
1969 2
1970 3
1972 4
1973 2
1974 1
1975 1
1977 1
1979 4
1981 1
1983 1
1984 1
1986 3
1987 1
1988 1
1989 4
1990 2
1991 4
1992 6
1993 13
1994 8
1995 8
1996 10
1997 4
1998 3
1999 7
2000 5
2001 7
2002 19
2003 21
2004 16
2005 26
2006 46
2007 63
2008 71
2009 75
2010 100
2011 97
2012 75
2013 67
2014 94
2015 87
2016 73
2017 88
2018 56
2019 77
2020 100
2021 87
2022 96
2023 76
2024 64
2025 49
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,598 results

Results by year

Filters applied: Review. Clear all
Page 1
Niacinamide: a review on dermal delivery strategies and clinical evidence.
Ong RR, Goh CF. Ong RR, et al. Drug Deliv Transl Res. 2024 Dec;14(12):3512-3548. doi: 10.1007/s13346-024-01593-y. Epub 2024 May 9. Drug Deliv Transl Res. 2024. PMID: 38722460 Review.
Therefore, a fundamental understanding of the skin permeation behaviour of niacinamide becomes crucial for formulation design. Given the paucity of a comprehensive review on this aspect, we provide insights into the mechanisms of action of topically applied niacinamide …
Therefore, a fundamental understanding of the skin permeation behaviour of niacinamide becomes crucial for formulation design. Given …
Niacinamide - mechanisms of action and its topical use in dermatology.
Wohlrab J, Kreft D. Wohlrab J, et al. Skin Pharmacol Physiol. 2014;27(6):311-5. doi: 10.1159/000359974. Epub 2014 Jun 27. Skin Pharmacol Physiol. 2014. PMID: 24993939 Review.
Niacinamide, an amide of vitamin B3 (niacin), is a hydrophilic endogenous substance. Its effects after epicutaneous application have long been described in the literature. Given a sufficient bioavailability, niacinamide has antipruritic, antimicrobial, vasoactive, p …
Niacinamide, an amide of vitamin B3 (niacin), is a hydrophilic endogenous substance. Its effects after epicutaneous application have …
The role of nicotinamide in acne treatment.
Walocko FM, Eber AE, Keri JE, Al-Harbi MA, Nouri K. Walocko FM, et al. Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12481. Epub 2017 Feb 21. Dermatol Ther. 2017. PMID: 28220628 Review.
Safe and effective treatment options for acne vulgaris are needed to address side effects and increasing rates of antibiotic resistance from current treatments. ...We searched PubMed for clinical studies using nicotinamide for treatment of acne vulgaris. We s …
Safe and effective treatment options for acne vulgaris are needed to address side effects and increasing rates of antibiotic resistan …
Final report of the safety assessment of niacinamide and niacin.
Cosmetic Ingredient Review Expert Panel. Cosmetic Ingredient Review Expert Panel. Int J Toxicol. 2005;24 Suppl 5:1-31. doi: 10.1080/10915810500434183. Int J Toxicol. 2005. PMID: 16596767 Review.
Both are GRAS direct food additives and nutrient and/or dietary supplements. Niacinamide may be used in clinical treatment of hypercholesteremia and Niacin in prevention of pellegra and treatment of certain psychological disorders. ...Skin irritation tests of …
Both are GRAS direct food additives and nutrient and/or dietary supplements. Niacinamide may be used in clinical treatment of …
A review of nicotinamide: treatment of skin diseases and potential side effects.
Rolfe HM. Rolfe HM. J Cosmet Dermatol. 2014 Dec;13(4):324-8. doi: 10.1111/jocd.12119. J Cosmet Dermatol. 2014. PMID: 25399625 Review.
Nicotinamide, also known as niacinamide, is the amide form of vitamin B3. It is a precursor of essential coenzymes for numerous reactions in the body including adenosine triphosphate (ATP) production. ...The use of topical nicotinamide in the treatment of acne vulga …
Nicotinamide, also known as niacinamide, is the amide form of vitamin B3. It is a precursor of essential coenzymes for numerous react …
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS. Nash P, et al. Ann Rheum Dis. 2021 Jan;80(1):71-87. doi: 10.1136/annrheumdis-2020-218398. Epub 2020 Nov 6. Ann Rheum Dis. 2021. PMID: 33158881 Free PMC article.
RESULTS: The Task Force agreed on and developed four general principles and a total of 26 points for consideration which were grouped into six areas addressing indications, treatment dose and comedication, contraindications, pretreatment screening and risks, laboratory and …
RESULTS: The Task Force agreed on and developed four general principles and a total of 26 points for consideration which were grouped into s …
Nicotinamide: Mechanism of action and indications in dermatology.
Bains P, Kaur M, Kaur J, Sharma S. Bains P, et al. Indian J Dermatol Venereol Leprol. 2018;84(2):234-237. doi: 10.4103/ijdvl.IJDVL_286_17. Indian J Dermatol Venereol Leprol. 2018. PMID: 29405129 Free article. Review. No abstract available.
Treatment of Hepatocellular Carcinoma.
Díaz-González Á, Reig M, Bruix J. Díaz-González Á, et al. Dig Dis. 2016;34(5):597-602. doi: 10.1159/000445275. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332893 Review.
At advanced stage (BCLC C), the recommended treatment is sorafenib. Finally, at the end stage (BCLC D), symptomatic treatment is the suggested option. ...These patients then move to the treatment that would correspond to the next stage/s....
At advanced stage (BCLC C), the recommended treatment is sorafenib. Finally, at the end stage (BCLC D), symptomatic treatment …
Management of hepatocellular carcinoma: an update.
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Bruix J, et al. Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199. Hepatology. 2011. PMID: 21374666 Free PMC article. No abstract available.
Sorafenib.
Rini BI. Rini BI. Expert Opin Pharmacother. 2006 Mar;7(4):453-61. doi: 10.1517/14656566.7.4.453. Expert Opin Pharmacother. 2006. PMID: 16503817 Review.
1,598 results